Dosilicon Co., Ltd. (SHA:688110)
China flag China · Delayed Price · Currency is CNY
73.20
+12.20 (20.00%)
Aug 7, 2025, 2:45 PM CST

Sage Therapeutics Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
31,73410,87515,19211,57419,981-
Upgrade
Market Cap Growth
32.71%-28.42%31.27%-42.08%--
Upgrade
Enterprise Value
30,5479,91013,2429,00119,855-
Upgrade
Last Close Price
73.2024.9034.4326.0844.81-
Upgrade
PE Ratio
---62.4176.32-
Upgrade
Forward PE
-40.2240.2225.25--
Upgrade
PS Ratio
46.8816.9728.6310.1017.61-
Upgrade
PB Ratio
9.593.234.112.815.04-
Upgrade
P/TBV Ratio
10.073.394.342.955.24-
Upgrade
P/FCF Ratio
----306.83-
Upgrade
P/OCF Ratio
----170.02-
Upgrade
EV/Sales Ratio
45.1215.4624.967.8517.51-
Upgrade
EV/EBITDA Ratio
---54.3165.41-
Upgrade
EV/EBIT Ratio
---65.4870.09-
Upgrade
EV/FCF Ratio
-99.68---304.90-
Upgrade
Debt / Equity Ratio
0.010.010.010.020.010.06
Upgrade
Debt / EBITDA Ratio
---0.410.140.69
Upgrade
Debt / FCF Ratio
----0.670.19
Upgrade
Asset Turnover
0.190.170.130.270.461.07
Upgrade
Inventory Turnover
0.670.680.981.582.151.78
Upgrade
Quick Ratio
15.5512.7815.5215.3219.454.03
Upgrade
Current Ratio
26.6520.3421.7919.0821.397.04
Upgrade
Return on Equity (ROE)
-5.51%-4.96%-7.70%5.38%12.35%2.45%
Upgrade
Return on Assets (ROA)
-4.09%-3.95%-6.62%2.02%7.17%3.36%
Upgrade
Return on Capital (ROIC)
-4.21%-4.07%-6.83%2.10%7.56%3.87%
Upgrade
Return on Capital Employed (ROCE)
---3.30%7.10%6.00%
Upgrade
Earnings Yield
-0.57%-1.54%-2.02%1.60%1.31%-
Upgrade
FCF Yield
-0.97%-2.93%-2.17%-2.95%0.33%-
Upgrade
Dividend Yield
---0.48%0.40%-
Upgrade
Payout Ratio
---43.69%0.56%23.45%
Upgrade
Buyback Yield / Dilution
2.98%0.90%-0.51%-29.88%-4.44%-11.68%
Upgrade
Total Shareholder Return
-0.90%-0.51%-29.39%-4.04%-11.68%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.